Post by Bjørås Group

How do you develop treatments for a disease affecting only around 100 people worldwide? By combining patient-derived stem cells, organoid technology, and advanced disease modeling, we hope to better understand ultra-rare disorders such as EMARDD and identify potential therapeutic strategies🔬🧬 Thank you to Mikkel and his family for sharing their story and highlighting the importance of research for patients living with rare genetic diseases 💙 Mikkel's story was recently featured by TV 2. Read the full article here: https://lnkd.in/ev7XTabp #RareDisease #Organoids #PrecisionMedicine #NTNU #BjøråsGroup Magnar Bjørås Emil W. Niklas Nonboe Andersen Magnar Bjørås Bjørås Group